期刊文献+

乙醇室间隔消融术治疗肥厚型梗阻性心肌病研究进展 被引量:1

Progress in Research on Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
下载PDF
导出
摘要 肥厚型梗阻性心肌病是青年人心源性猝死的最常见原因。严重者应及时治疗,最适病人的筛选、影像技术的辅助、并发症的控制和操作技术的提升将使乙醇室间隔消融术成为治疗肥厚型梗阻性心肌病一种很有前途的方法。 Hypertrophic obstructive cardiomyopathy is the most common cause of sudden cardiac death in young people. Patients with severe symptoms require prompt diagnosis and treatment. Alcohol septal ablation is becoming a promising therapy for carefully selected patients who have obstructive hypertrophic cardiomyopathy.
出处 《心血管病学进展》 CAS 2014年第4期492-495,共4页 Advances in Cardiovascular Diseases
关键词 肥厚型梗阻性心肌病 乙醇室间隔消融术 治疗 hypertrophic obstructive cardiomyopathy alcohol septal ablation treatment
  • 相关文献

参考文献27

  • 1Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AIIA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy : a report of the Amer- ican College of Cardiology Foundatio JAmerican Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Associa- tion for Thoracic Surgery, American Society of Echocardiography, American So-ciety of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography amt Interventions, and S )t iety of Thoracic Surgeons [ J ]. J Am Coil Cardiol, 20 l 1, 58 (25) :212-260.
  • 2Maron B J, Maron MS. Hypertrophic cardiomyopathy [ J ]. Lancet, 2013, 381 ( 9862 ) : 242 -255.
  • 3Khouzam RN, Naidu SS. Current status and future perspectives on alcohol sep- tal ablation for hypertrophic obstructive cardiomyopathy[ J ]. Curr Cardiol Rep, 2014, 16(5) :1-10.
  • 4Sigwart U, Grbic M, Essinger A, et al. hnprovement of left vent cular function after percutaneous transluminal coronary angioplasty[J]]. Am J Cardiol, 1982, 49(4) :651-657.
  • 5lnoue H, Wailer BF, Zipes DP. lntracoronary ethyl alcohol or phem- l injection ablates aconitine-induced ventricular tachycardia in dogs[J]. J Am Coil Cardi- ol, 1987, 10(6) :1342-1349.
  • 6Bmgada P, de Swart H, Smeets JL, et al. Transcoronary chmnical ablation of ventricular tachycardia[J]. Circulation, 1989, 79(3) :475-482.
  • 7Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive car- diomyopathy [ J ]. Lancet, 1995, 346 ( 8969 ) :211-214.
  • 8Bradham WS, Gunasinghe H, Holder JR, et al. Release of matrix metallopro- teinases following alcohol septal ablation in hypertrophic obstructive (ardiomyop- athy[J]. J Am Coil Cardiol, 2002, 40(12) :2165-2173.
  • 9Wallace EL, Thompson J J, Faulkner MW, et al. Septal perforator anatomy and variability of perfusion bed t)y myocardial contrast echocardiography : a study of hypertrophic cardion yopathy patients undergoing alcohol septal ablation [ J ]. J Int Cardiol, 2013, 26(6) :604-612.
  • 10Faber L, Ziemssen P, Seggewiss H. Targeting percutaneous transluminal septal ablation for hypertrophic obstlalctive cardiomyopathy by intraprocedural echocar- diographic monitoring[ J ]. J Am Soc Echocardiogr, 2000, 13 ( 12 ) : 1074- 1079.

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部